Financial Statements — NOEMR
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 |
|---|
| Cash & Equivalents | 0.01 | 0.03 | 0.34 | 0.47 | 0.63 | 0.00 |
| Total Current Assets | 0.11 | 0.21 | 0.49 | 0.64 | 0.89 | 0.00 |
| Total Non-current Assets* | 72.74 | 71.87 | 71.43 | 70.72 | 70.02 | 0.25 |
| Total Assets | 72.85 | 72.08 | 71.92 | 71.36 | 70.91 | 0.26 |
| Short-term Debt | -- | -- | -- | -- | -- | 0.01 |
| Total Current Liabilities | 0.52 | 0.08 | 0.62 | 0.49 | 0.46 | -- |
| Total Non-current Liabilities* | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 | -- |
| Total Liabilities | 2.59 | 2.15 | 2.69 | 2.56 | 2.53 | 0.66 |
| Retained Earnings | (2.34) | (1.96) | (1.66) | (1.54) | (1.47) | (0.43) |
| Total Stockholder Equity | (2.34) | (1.96) | (1.66) | (1.54) | (1.47) | (0.40) |
* Derived from reported values
Income Statement
(in thousands USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 |
|---|
| Selling, General & Admin | 182.35 | 196.73 | 158.78 | 154.49 | 162.31 | 170.72 | 179.15 | 26.53 |
| Operating Income | (182.35) | (196.73) | (158.78) | (154.49) | (162.31) | (170.72) | (179.15) | (26.53) |
| Pretax Income | 454.75 | 435.43 | 530.24 | 583.34 | 565.64 | 552.42 | 130.66 | -- |
| Tax Provision | 127.18 | 126.26 | 137.97 | 148.53 | 146.75 | 146.02 | -- | -- |
| Net Income | 327.57 | 309.16 | 392.26 | 434.81 | 418.89 | 406.40 | 69.62 | (26.53) |
| Basic EPS | -- | -- | -- | -- | -- | -- | -- | (0.01) |
| Diluted EPS | -- | -- | -- | -- | -- | -- | -- | (0.01) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 |
|---|
| Operating Cash Flow | (0.09) | (1.14) | (0.06) | (0.13) | (0.23) | (0.34) | (0.21) | (0.09) |
| Investing Cash Flow | (0.23) | 0.87 | 0.00 | 0.00 | 0.06 | 0.02 | -- | -- |
| Financing Cash Flow | 0.30 | -- | -- | -- | 0.01 | 0.06 | 70.16 | 0.10 |
